BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu C, von Brunn A, Zhu D. Cyclophilin A and CD147: novel therapeutic targets for the treatment of COVID-19. Med Drug Discov 2020;7:100056. [PMID: 32835213 DOI: 10.1016/j.medidd.2020.100056] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 12.5] [Reference Citation Analysis]
Number Citing Articles
1 Hristov DR, Gomez-Marquez J, Wade D, Hamad-Schifferli K. SARS-CoV-2 and approaches for a testing and diagnostic strategy. J Mater Chem B 2021;9:8157-73. [PMID: 34494642 DOI: 10.1039/d1tb00674f] [Reference Citation Analysis]
2 Jafarpour R, Pashangzadeh S, Dowran R. Host factors: Implications in immunopathogenesis of COVID-19. Pathol Res Pract 2021;228:153647. [PMID: 34749207 DOI: 10.1016/j.prp.2021.153647] [Reference Citation Analysis]
3 Pang L, Liu Y, Shen M, Ye J, Chen R, Lan Z, Wu Z, Guo Y, Zhang P. Influence of aging on deterioration of patients with COVID-19. Aging (Albany NY) 2020;12:26248-62. [PMID: 33232272 DOI: 10.18632/aging.202136] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lv JJ, Wang H, Cui HY, Liu ZK, Zhang RY, Lu M, Li C, Yong YL, Liu M, Zhang H, Zhang TJ, Zhang K, Li G, Nan G, Zhang C, Guo SP, Wang L, Chen ZN, Bian H. Blockade of Macrophage CD147 Protects Against Foam Cell Formation in Atherosclerosis. Front Cell Dev Biol 2020;8:609090. [PMID: 33490072 DOI: 10.3389/fcell.2020.609090] [Reference Citation Analysis]
5 Nunn AVW, Guy GW, Brysch W, Botchway SW, Frasch W, Calabrese EJ, Bell JD. SARS-CoV-2 and mitochondrial health: implications of lifestyle and ageing. Immun Ageing 2020;17:33. [PMID: 33292333 DOI: 10.1186/s12979-020-00204-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
6 Hussen J, Kandeel M, Hemida MG, Al-Mubarak AIA. Antibody-Based Immunotherapeutic Strategies for COVID-19. Pathogens. 2020;9. [PMID: 33167401 DOI: 10.3390/pathogens9110917] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
7 Kumar S, Shanker OR, Kumari N, Tripathi M, Chandra PS, Dixit AB, Banerjee J. Neuromodulatory effects of SARS-CoV2 infection: Possible therapeutic targets. Expert Opin Ther Targets 2021;25:509-19. [PMID: 34232801 DOI: 10.1080/14728222.2021.1953475] [Reference Citation Analysis]
8 Vianello A, Del Turco S, Babboni S, Silvestrini B, Ragusa R, Caselli C, Melani L, Fanucci L, Basta G. The Fight against COVID-19 on the Multi-Protease Front and Surroundings: Could an Early Therapeutic Approach with Repositioning Drugs Prevent the Disease Severity? Biomedicines 2021;9:710. [PMID: 34201505 DOI: 10.3390/biomedicines9070710] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Pata S, Surinkaew S, Takheaw N, Laopajon W, Chuensirikulchai K, Kasinrerk W. Differential CD147 Functional Epitopes on Distinct Leukocyte Subsets. Front Immunol 2021;12:704309. [PMID: 34421910 DOI: 10.3389/fimmu.2021.704309] [Reference Citation Analysis]
10 Liang W, Zhang Y, Li M, Al-Shaebi F, Li J, Zhang J, Wei L. Cyclophilin A Inhibits Human Respiratory Syncytial Virus (RSV) Replication by Binding to RSV-N through Its PPIase Activity. J Virol 2021;95:e0056321. [PMID: 34011546 DOI: 10.1128/JVI.00563-21] [Reference Citation Analysis]
11 Behl T, Kaur I, Aleya L, Sehgal A, Singh S, Sharma N, Bhatia S, Al-Harrasi A, Bungau S. CD147-spike protein interaction in COVID-19: Get the ball rolling with a novel receptor and therapeutic target. Sci Total Environ 2021;808:152072. [PMID: 34863742 DOI: 10.1016/j.scitotenv.2021.152072] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Gomez Marti JL, Brufsky AM. Considerations of the effects of commonly investigated drugs for COVID-19 in the cholesterol synthesis pathway. Expert Opin Pharmacother 2021;22:947-52. [PMID: 33703986 DOI: 10.1080/14656566.2021.1897104] [Reference Citation Analysis]
13 Ben Moftah M, Eswayah A. Repurposing of Hydroxyurea Against COVID-19: A Promising Immunomodulatory Role. Assay Drug Dev Technol 2022;20:55-62. [PMID: 34990284 DOI: 10.1089/adt.2021.090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Lokhande AS, Devarajan PV. A review on possible mechanistic insights of Nitazoxanide for repurposing in COVID-19. Eur J Pharmacol 2021;891:173748. [PMID: 33227285 DOI: 10.1016/j.ejphar.2020.173748] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
15 Cavezzi A, Menicagli R, Troiani E, Corrao S. COVID-19, Cation Dysmetabolism, Sialic Acid, CD147, ACE2, Viroporins, Hepcidin and Ferroptosis: A Possible Unifying Hypothesis. F1000Res 2022;11:102. [DOI: 10.12688/f1000research.108667.1] [Reference Citation Analysis]
16 Scorei IR, Biţă A, Mogoşanu GD. Letter to the Editor: Boron enhances the antiviral activity of the curcumin against SARS-CoV-2. Rom J Morphol Embryol 2020;61:967-70. [PMID: 33817742 DOI: 10.47162/RJME.61.3.39] [Reference Citation Analysis]
17 Evans JP, Liu SL. Role of host factors in SARS-CoV-2 entry. J Biol Chem 2021;297:100847. [PMID: 34058196 DOI: 10.1016/j.jbc.2021.100847] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
18 [DOI: 10.1101/2020.07.25.221036] [Cited by in Crossref: 16] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
19 Burtey S, Sallée M. [Kidney damage in COVID-19]. Nephrol Ther 2021;17:203-7. [PMID: 34266783 DOI: 10.1016/j.nephro.2021.06.002] [Reference Citation Analysis]
20 Warner FJ, Rajapaksha H, Shackel N, Herath CB. ACE2: from protection of liver disease to propagation of COVID-19. Clin Sci (Lond). 2020;134:3137-3158. [PMID: 33284956 DOI: 10.1042/cs20201268] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
21 Menter T, Tzankov A, Bruder E. [Impact of SARS-CoV-2/COVID-19 on the placenta]. Pathologe 2021. [PMID: 34115179 DOI: 10.1007/s00292-021-00952-7] [Reference Citation Analysis]
22 Cavezzi A, Menicagli R, Troiani E, Corrao S. COVID-19, Cation Dysmetabolism, Sialic Acid, CD147, ACE2, Viroporins, Hepcidin and Ferroptosis: A Possible Unifying Hypothesis. F1000Res 2022;11:102. [DOI: 10.12688/f1000research.108667.2] [Reference Citation Analysis]
23 Şahin S, Dege N. Synthesis, characterization, X-ray, HOMO-LUMO, MEP, FT-IR, NLO, Hirshfeld surface, ADMET, boiled-egg model properties and molecular docking studies with human cyclophilin D (CypD) of a Schiff base compound: (E)-1-(5-nitro-2-(piperidin-1-yl)phenyl)-N-(3-nitrophenyl)methanimine. Polyhedron 2021;205:115320. [DOI: 10.1016/j.poly.2021.115320] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Makvandi P, Chen M, Sartorius R, Zarrabi A, Ashrafizadeh M, Dabbagh Moghaddam F, Ma J, Mattoli V, Tay FR. Endocytosis of abiotic nanomaterials and nanobiovectors: Inhibition of membrane trafficking. Nano Today 2021;40:101279. [PMID: 34518771 DOI: 10.1016/j.nantod.2021.101279] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Ahmad S, Waheed Y, Abro A, Abbasi SW, Ismail S. Molecular screening of glycyrrhizin-based inhibitors against ACE2 host receptor of SARS-CoV-2. J Mol Model 2021;27:206. [PMID: 34169390 DOI: 10.1007/s00894-021-04816-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
26 Afzali S, Ashtarnakhaei M, Shiari S, Shirkavand A, Farivar S. Human Cell Receptors and Downstream Cascades: A Review of Molecular Aspects and Potential Therapeutic Targets in COVID-19. Arch Pediatr Infect Dis 2021;10. [DOI: 10.5812/pedinfect.113298] [Reference Citation Analysis]
27 Bortolotti D, Simioni C, Neri LM, Rizzo R, Semprini CM, Occhionorelli S, Laface I, Sanz JM, Schiuma G, Rizzo S, Varano G, Beltrami S, Gentili V, Gafà R, Passaro A. Relevance of VEGF and CD147 in different SARS-CoV-2 positive digestive tracts characterized by thrombotic damage. FASEB J 2021;35:e21969. [PMID: 34822202 DOI: 10.1096/fj.202100821RRR] [Reference Citation Analysis]
28 Devaux CA, Melenotte C, Piercecchi-Marti MD, Delteil C, Raoult D. Cyclosporin A: A Repurposable Drug in the Treatment of COVID-19? Front Med (Lausanne) 2021;8:663708. [PMID: 34552938 DOI: 10.3389/fmed.2021.663708] [Reference Citation Analysis]
29 Sharma I, Kumari P, Sharma A, Saha SC. SARS-CoV-2 and the reproductive system: known and the unknown..!! Middle East Fertil Soc J 2021;26:1. [PMID: 33437145 DOI: 10.1186/s43043-020-00046-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
30 McGill AR, Kahlil R, Dutta R, Green R, Howell M, Mohapatra S, Mohapatra SS. SARS-CoV-2 Immuno-Pathogenesis and Potential for Diverse Vaccines and Therapies: Opportunities and Challenges. Infect Dis Rep 2021;13:102-25. [PMID: 33557330 DOI: 10.3390/idr13010013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
31 Geng J, Chen L, Yuan Y, Wang K, Wang Y, Qin C, Wu G, Chen R, Zhang Z, Wei D, Du P, Zhang J, Lin P, Zhang K, Deng Y, Xu K, Liu J, Sun X, Guo T, Yang X, Wu J, Jiang J, Li L, Zhang K, Wang Z, Zhang J, Yan Q, Zhu H, Zheng Z, Miao J, Fu X, Yang F, Chen X, Tang H, Zhang Y, Shi Y, Zhu Y, Pei Z, Huo F, Liang X, Wang Y, Wang Q, Xie W, Li Y, Shi M, Bian H, Zhu P, Chen ZN. CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 and its variants delta, alpha, beta, and gamma. Signal Transduct Target Ther 2021;6:347. [PMID: 34564690 DOI: 10.1038/s41392-021-00760-8] [Reference Citation Analysis]
32 Hussein MAA, Hussein HAM, Thabet AA, Selim KM, Dawood MA, El-adly AM, Wardany AA, Sobhy A, Magdeldin S, Osama A, Anwar AM, Abdel-wahab M, Askar H, Bakhiet EK, Sultan S, Ezzat AA, Abdel Raouf U, Afifi MM. Human Wharton’s Jelly Mesenchymal Stem Cells Secretome Inhibits Human SARS-CoV-2 and Avian Infectious Bronchitis Coronaviruses. Cells 2022;11:1408. [DOI: 10.3390/cells11091408] [Reference Citation Analysis]
33 Ebner B, Volz Y, Mumm JN, Stief CG, Magistro G. The COVID-19 pandemic - what have urologists learned? Nat Rev Urol 2022. [PMID: 35418709 DOI: 10.1038/s41585-022-00586-1] [Reference Citation Analysis]
34 Shilts J, Crozier TWM, Greenwood EJD, Lehner PJ, Wright GJ. No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor. Sci Rep 2021;11:413. [PMID: 33432067 DOI: 10.1038/s41598-020-80464-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 38] [Article Influence: 28.0] [Reference Citation Analysis]
35 Al-Kuraishy HM, Al-Gareeb AI, Mostafa-Hedeab G, Kasozi KI, Zirintunda G, Aslam A, Allahyani M, Welburn SC, Batiha GE. Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19. Front Immunol 2021;12:749291. [PMID: 34867978 DOI: 10.3389/fimmu.2021.749291] [Reference Citation Analysis]
36 Deng H, Yan X, Yuan L. Human genetic basis of coronavirus disease 2019. Signal Transduct Target Ther 2021;6:344. [PMID: 34545062 DOI: 10.1038/s41392-021-00736-8] [Reference Citation Analysis]
37 Zhou YW, Xie Y, Tang LS, Pu D, Zhu YJ, Liu JY, Ma XL. Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies. Signal Transduct Target Ther 2021;6:317. [PMID: 34446699 DOI: 10.1038/s41392-021-00733-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
38 Ali MM, Mirza I, Naquiallah D, Hassan C, Masrur M, Bianco FM, Mahmoud AM. CD147 Levels in Blood and Adipose Tissues Correlate with Vascular Dysfunction in Obese Diabetic Adults. JCDD 2022;9:7. [DOI: 10.3390/jcdd9010007] [Reference Citation Analysis]